Results 41 to 50 of about 88,639 (264)

An Analysis of Optical Coherence Tomography Angiography (OCT-A) Perfusion Density Maps in Patients Treated for Retinal Vein Occlusion with Intravitreal Aflibercept

open access: yesDiagnostics, 2023
Aim: The primary goal of this study was to evaluate the reduction in non-perfusion area and improvement in blood flow as well as the reduction in retinal edema on optical coherence tomography angiography (OCT-A) in patients with retinal vein occlusion ...
Dorota Śpiewak   +3 more
doaj   +1 more source

Integrated results from the COPERNICUS and GALILEO studies. [PDF]

open access: yes, 2017
OBJECTIVES: To report on the efficacy and safety of intravitreal aflibercept in patients with macular edema secondary to central retinal vein occlusion (CRVO) in an integrated analysis of COPERNICUS and GALILEO.
Ahlers, Christiane   +13 more
core   +3 more sources

Bilateral Central Retinal Vein Occlusion in a 40-Year-Old Man with Severe Coronavirus Disease 2019 (COVID-19) Pneumonia

open access: yesThe American journal of case reports, 2020
Patient: Male, 40-year-old Final Diagnosis: Central retinal vein occlusion Symptoms: Blurring of vision • leg pain Medication: — Clinical Procedure: — Specialty: General and Internal Medicine Objective: Rare co-existance of disease or pathology ...
W. Gaba   +4 more
semanticscholar   +1 more source

MODERN APPROACHES TO DIAGNOSTICS AND TREATMENT OF RETINAL VEIN OCCLUSION

open access: yesСибирский научный медицинский журнал, 2019
Retinal vein occlusion is the one of the most common diseases, which amounts to 60 % of all acute vascular ocular pathology, and takes second place in the severity of retinal lesions and prognosis after diabetic retinopathy.
P. L. Volodin   +2 more
doaj   +1 more source

Risk Factors for Central and Branch Retinal Vein Occlusion: A Meta-Analysis of Published Clinical Data [PDF]

open access: yes, 2014
Retinal vein occlusion (RVO) is a major cause of vision loss. Of the two main types of RVO, branch retinal vein occlusion (BRVO) is 4 to 6 times more prevalent than central retinal vein occlusion (CRVO).
Kolář Petr
core   +4 more sources

Optical coherence tomography-based consensus definition for lamellar macular hole. [PDF]

open access: yes, 2020
BackgroundA consensus on an optical coherence tomography definition of lamellar macular hole (LMH) and similar conditions is needed.MethodsThe panel reviewed relevant peer-reviewed literature to reach an accord on LMH definition and to differentiate LMH ...
Bottoni, Ferdinando   +14 more
core   +2 more sources

association oF systemic Diseases witH retinal vein occlusive Disease

open access: yesJournal of Nepal Medical Association, 2006
Retinal vein occlusion (RVO) is the second commonest vascular disease of the eye, second only to Diabetic Retinopathy. The association of the retinal vein occlusion with other systemic disease likes hypertension, diabetes mellitus and others has been ...
Rajesh Kishor Shrestha   +3 more
doaj   +1 more source

Widening use of dexamethasone implant for the treatment of macular edema [PDF]

open access: yes, 2017
Sustained-release intravitreal 0.7 mg dexamethasone (DEX) implant is approved in Europe for the treatment of macular edema related to diabetic retinopathy, branch retinal vein occlusion, central retinal vein occlusion, and non-infectious uveitis.
Avitabile T.   +9 more
core   +2 more sources

ROLE OF BEVACIZUMAB FOR PREVENTION OF NEOVASCULAR GLAUCOMA IN ACUTE RETINAL VEIN OCCLUSION [PDF]

open access: yesJournal of University Medical & Dental College, 2018
: There is a possibility of developing neovascular glaucoma in ischemic type of retinal vein occlusion. Purpose of the study is to determine the role of anti VEGF agent bevacizumab for prevention of neovascular glaucoma in ischemic type of retinal vein ...
Bassam Mubarik , Adeen Akram
doaj   +1 more source

An eighteen-month follow-up study on the effects of intravitreal dexamethasone implant in diabetic macular edema refractory to anti-VEGF therapy [PDF]

open access: yes, 2016
AIM: To evaluate the long-term efficacy and safety of dexamethasone implants in subjects affected by diabetic macular edema (DME) resistant to anti-vascular endothelial growth factor (VEGF) therapy. METHODS: Thirty-two DME patients were enrolled.
Carnovale, Anna   +7 more
core   +1 more source

Home - About - Disclaimer - Privacy